Menu
Recruiting NCT07660393

The Use of Virtual Reality Glasses in Women With Premature Rupture of Membranes

No phase Interventional Fetal Health Anxiety Prenatal Distress Prenatal Attachment

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Standard prenatal care, Nature-themed video.
Who it may be relevant to
Registry conditions: Fetal Health Anxiety, Prenatal Distress, Prenatal Attachment. Basic parameters: 18 years — 50 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women With Premature Rupture of Membranes: A Randomized Controlled Trial

Overview

The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women with Premature Rupture of Membranes: A Randomized Controlled Trial

Detailed description

This study is a randomized controlled trial. The study population will consist of nulliparous pregnant women hospitalized with a diagnosis of preterm premature rupture of membranes (PPROM) in the Perinatology Clinic of Konya City Hospital between June 2025 and January 2027. A total of 176 pregnant women who will be giving birth for the first time will be included in the study (intervention group: n = 88; control group: n = 88). In the intervention group, pregnant women with PPROM will watch a nature-themed video accompanied by natural sounds selected by the researchers through a virtual reality headset (VRH) twice daily for three consecutive days, with each session lasting at least five minutes. The control group will receive the standard antenatal care provided by the hospital. Data will be collected using a Personal Information Form, the Fetal Health Anxiety Scale, the Prenatal Distress Questionnaire, and the Prenatal Attachment Inventory.

Interventions

  • Other Standard prenatal care
    The control group will receive standard prenatal care and treatment provided by the hospital. After the study is completed, control group participants will be shown nature-themed videos via Virtual Reality Glasses (VRG) if they wish.
  • Other Nature-themed video
    Pregnant women with premise rupture of membranes (PRM) in the intervention group will be shown a nature-themed video prepared by the researchers with nature sounds via Virtual Reality Glasses (VRG) twice a day for at least five minutes each time for three days.

Primary outcome measures

  • Comparison of sociodemographic characteristics of pregnant women with premature rupture of membranes prior to intervention using questionnaires. [Time frame: 6 months]
  • Comparison of mean scores on the Fetal Health Concern Scale among groups of pregnant women. [Time frame: 6 months]
  • Comparison of mean Prenatal Distress Scale scores among groups of pregnant women. [Time frame: 6 months]
  • Comparison of mean Prenatal Attachment Inventory scores among groups of pregnant women. [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Being 18 years of age or older
  • Being nulliparous
  • Having a diagnosis of preterm premature rupture of membranes (PPROM)
  • Being between 24 and 37 weeks of gestation
  • Having a singleton pregnancy
  • Being hospitalized in the ward for at least 3 days
  • Having no visual or hearing impairment
  • Being communicative and mentally and psychologically healthy
  • Being able to speak and express oneself in Turkish

Exclusion criteria

  • Having an additional diagnosis besides preterm premature rupture of membranes (PPROM) (e.g., preeclampsia, fetal distress, fetal anomalies, gestational diabetes, bleeding, etc.)
  • Having a chronic disease (e.g., hypertension, diabetes mellitus, thyroid disorders, etc.)
  • Having conceived through assisted reproductive technologies (ART)
  • Having any skin infection.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Turkey (Türkiye) · 1 center
  • Seyhan Çankaya — Konya

Identifiers

NCT: NCT07660393 · 2025/1150

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗